Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
September 6, 2024 11:07 AM 3 min read

UiPath Q2 Results Reflect Restructuring Benefits, Analysts Praise 'Laser-Focus' On AI

by Priya Nigam Benzinga Staff Writer
Follow

Shares of UiPath Inc (NYSE:PATH) are down Friday despite the company’s reporting in-line fiscal second-quarter results.

Here are some key analyst takeaways:

  • BMO Capital Markets analyst Keith Bachman maintained a Market Perform rating, while raising the price target from $14 to $15.
  • DA Davidson analyst Gil Luria reaffirmed a Neutral rating, while lifting the price target from $13 to $15.
  • JPMorgan analyst Mark Murphy reiterated an Overweight rating and price target of $19.
  • RBC Capital Markets analyst Matthew Hedberg maintained a Sector Perform rating and price target of $16.
  • KeyBanc Capital Markets analyst Jason Celino reaffirmed a Sector Weight rating on the stock.KeyBanc Capital Markets

Check out other analyst stock ratings.

BMO Capital Markets: UiPath's quarterly results were broadly in-line with low expectations, Bachman said in a note. This is a positive, after the previous quarter's execution challenges, amid a leadership change, he added.  

The company reported annual recurring revenues of $1.55 billion. This represents 19% year-on-year growth, but a deceleration of 2 points versus the prior quarter, the analyst stated. "We are encouraged by $850M cloud ARR, representing more than half of ARR and growing by 65% y/y, demonstrating PATH's cloud-first strategy is gaining traction," he further wrote.

DA Davidson: UiPath's fiscal second-quarter results "demonstrated early success in the company’s efforts to refocus on customer centricity," Luria said. The company raised its full-year adjusted operating income guidance from $145 million to $170 million.

"The company is laser-focused on cementing its reputation as the world’s leader in enabling actions from AI insight," the analyst wrote. UiPath had several enterprise wins and the net retention among its largest accounts remains at around 120%, he added.

JPMorgan: While there are macro uncertainties, overall conditions are stabilizing compared to the previous quarter, Murphy said. Better execution and streamlining efforts helped UiPath "adapt well to the current environment," he added.

The company indicated that "restructuring efforts primarily in its central functions, with a focus on sales operations and enablement, have enhanced efficiency and agility across the organization," the analyst wrote. Management announced "modest" raises to their full-year revenue and ARR guidance and "decent upticks for operating income and FCF guidance," he further stated.

RBC Capital Markets: UiPath showed "signs of stability," following a "sizable guide-down across the board," Hedberg said. Management raised their fiscal 2025 guidance by more than the beat. The company “continues to work towards its strategic initiatives," he added.

The company continues to focus on "realigning investments to higher ROI areas," adopting a stronger strategy for growth products, and focusing on expanding its channel partner relationships, the analyst stated. "Encouragingly, management highlighted strong early adoption and positive feedback from customers for Autopilot," he further wrote.

KeyBanc Capital Markets: UiPath reported quarterly revenue and operating margin at $316.3 million and 2%. It beat consensus of $303.7 million and 0.9%, respectively. Both gross retention and net retention declined in the quarter to 97% and 115%, from 98% and 118% in the previous quarter.

The company announced another share repurchase program of up to $500 million, the analyst stated. UiPath took its full-year guidance for operating income "meaningfully higher," implying operating margins of 12%, versus the Street estimates of 9.7%, , Celino wrote.

PATH Price Action: Shares of UiPath had declined by 5.34% to $12.06 at the time of publication on Friday.

Now Read:

  • Wall Street Sighs In Relief As August Jobs Numbers Ease Recession Fears: Small Caps Outperform, Dollar Trims Weekly Losses

Image courtesy of UiPath, Inc.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
Analyst ColorEarnings BeatsPrice TargetReiterationTop StoriesAnalyst RatingsMoversTechTrading IdeasBMO Capital MarketsDA DavidsonExpert IdeasGil LuriaJPMorganKeith BachmanKeyBanc Capital MarketsMark MurphyMatthew HedbergRBC Capital Markets
PATH Logo
PATHUiPath Inc
$11.221.08%
Overview
PATH Logo
PATHUiPath Inc
$11.221.08%
Overview
Beat the Market With Our Free Pre-Market Newsletter
Enter your email to get Benzinga's ultimate morning update: The PreMarket Activity Newsletter
Comments
Loading...